FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level: an exploratory cohort of the GERCOR OPTIMOX1 study.
about
Prognostic and predictive response factors in colorectal cancer patients: between hope and reality.Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR studyThe prognostic value of lactate dehydrogenase levels in colorectal cancer: a meta-analysis.Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer.Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
P2860
FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level: an exploratory cohort of the GERCOR OPTIMOX1 study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
FOLFOX in patients with metast ...... of the GERCOR OPTIMOX1 study.
@en
FOLFOX in patients with metast ...... of the GERCOR OPTIMOX1 study.
@nl
type
label
FOLFOX in patients with metast ...... of the GERCOR OPTIMOX1 study.
@en
FOLFOX in patients with metast ...... of the GERCOR OPTIMOX1 study.
@nl
prefLabel
FOLFOX in patients with metast ...... of the GERCOR OPTIMOX1 study.
@en
FOLFOX in patients with metast ...... of the GERCOR OPTIMOX1 study.
@nl
P2093
P356
P1433
P1476
FOLFOX in patients with metast ...... t of the GERCOR OPTIMOX1 study
@en
P2093
A Cervantes
A de Gramont
B Chibaudel
C Tournigand
P304
P356
10.1093/ANNONC/MDP012
P50
P577
2009-05-22T00:00:00Z